Brachytherapy Devices Market - By Product Type, By Technique, By Application, By End-use

Description

List of Tables

Global brachytherapy devices market size will grow at a 6.2% CAGR from 2023 to 2032. The increasing incidence of cancer worldwide, especially prostate and cervical cancers, is boosting demand for brachytherapy procedures, driving industry growth.

Additionally, advancements in technology are leading to more precise and efficient brachytherapy devices, reducing side effects and treatment durations. Elekta AB, based in Stockholm, Sweden, unveiled its inventive interventional radiotherapy solutions at Arab Health 2021. These solutions, personalized for cancer care and brain disorders, were designed primarily to target tumors while ensuring patient safety.

The growing awareness about the benefits of minimally invasive cancer treatment options will further drive business growth. Favorable reimbursement policies and a rising aging population will also fuel market expansion.

The brachytherapy devices market is categorized based on product type, technique, application, end-use, and region.

The electronic brachytherapy product segment will reflect a 6.5% CAGR over 2023-2032. The non-invasive nature of electronic brachytherapy, its reduced radiation exposure to healthy tissues, and shorter treatment times will drive growth in the segment. Moreover, technological advancements in electronic brachytherapy devices contribute to its rising popularity as a preferred treatment option for various cancers.

The high dose rate (HDR) technique will exhibit a 5.8% CAGR through 2032, driven by its precision, shorter treatment duration, and reduced radiation exposure to healthy tissues. These advantages will make HDR brachytherapy an increasingly preferred choice for cancer treatment in the coming years.

Based on application, the breast cancer segment is anticipated to depict a 6% CAGR from 2023 to 2032, driven by factors such as the increasing incidence of breast cancer, demand for minimally invasive treatments, and the ability of brachytherapy to provide targeted and effective radiation therapy for breast cancer patients.

Regionally, the Europe brachytherapy devices industry will grow at a 6.3% CAGR through 2032, driven by factors such as the rising prevalence of cancer, favorable reimbursement policies, and increasing adoption of advanced medical technologies in the region. The rising focus on minimizing the side effects of radiation therapy will further augment growth in the regional industry.

Product Code: 6561

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global brachytherapy devices market 360 degree synopsis, 2018 - 2032
2.2 Regional trends
2.3 Product type trends
2.4 Technique trends
2.5 Application trends
2.6 End-use trends

Chapter 3 Brachytherapy Devices Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Rise in prevalence of cancer
  - 3.5.1.2 Increasing awareness regarding cancer management
  - 3.5.1.3 Technological advancements
  - 3.5.1.4 Growing government initiatives regarding cancer treatment
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Dearth of skilled professionals
  - 3.5.2.2 High cost of devices
3.6 Growth potential analysis
- 3.6.1 By product type
- 3.6.2 By technique
- 3.6.3 By application
- 3.6.4 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Siemens Healthineers AG
- 4.1.2 Becton Dickinson & Company
- 4.1.3 Elekta AB
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 Brachytherapy Devices Market Estimates and Forecast, By Product Type (Revenue and Volume)

5.1 Key trends, by product type
5.2 Seeds
5.3 Applicators and afterloaders
5.4 Electronic brachytherapy

Chapter 6 Brachytherapy Devices Market Estimates and Forecast, By Technique (Revenue)

6.1 Key trends, by technique
6.2 High dose rate (HDR)
6.3 Low dose rate (LDR)

Chapter 7 Brachytherapy Devices Market Estimates and Forecast, By Application (Revenue)

7.1 Key trends, by application
7.2 Gynecological cancer
7.3 Prostate cancer
7.4 Breast cancer
7.5 Others

Chapter 8 Brachytherapy Devices Market Estimates and Forecast, By End-use (Revenue)

8.1 Key trends, by end-use
8.2 Hospitals
8.3 Specialty clinics
8.4 Others

Chapter 9 Brachytherapy Devices Market Estimates and Forecast, By Region (Revenue and Volume)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Switzerland
- 9.3.7 The Netherlands
- 9.3.8 Denmark
- 9.3.9 Poland
- 9.3.10 Sweden
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 New Zealand
- 9.4.7 Thailand
- 9.4.8 Vietnam
- 9.4.9 Indonesia
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Colombia
- 9.5.5 Chile
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Turkey

Chapter 10 Company Profiles

10.1 Elekta AB
10.2 Becton Dickinson & Company
10.3 Isoray Medical, Inc.
10.4 Eckert & Ziegler BEBIG
10.5 iCAD, Inc.
10.6 CIVCO Medical Solutions
10.7 Theragenics Corporation
10.8 Siemens Healthineers AG
10.9 Merit Medical Systems, Inc.
10.10 IsoAid
10.11 Carl Zeiss AG
10.12 Argon Medical Devices, Inc